Expression of Ferredoxin1 in cisplatin‑resistant ovarian cancer cells confers their resistance against ferroptosis induced by cisplatin.

Bibliographic Details
Title: Expression of Ferredoxin1 in cisplatin‑resistant ovarian cancer cells confers their resistance against ferroptosis induced by cisplatin.
Authors: Takahashi R; Division of Cell Physiology, Department of Physiology and Cell Biology, Graduate School of Medicine, Kobe University, Kobe 650‑0017, Japan., Kamizaki K; Division of Cell Physiology, Department of Physiology and Cell Biology, Graduate School of Medicine, Kobe University, Kobe 650‑0017, Japan., Yamanaka K; Department of Obstetrics and Gynecology, Graduate School of Medicine, Kobe University, Kobe 650‑0017, Japan., Terai Y; Department of Obstetrics and Gynecology, Graduate School of Medicine, Kobe University, Kobe 650‑0017, Japan., Minami Y; Division of Cell Physiology, Department of Physiology and Cell Biology, Graduate School of Medicine, Kobe University, Kobe 650‑0017, Japan.
Source: Oncology reports [Oncol Rep] 2023 Jun; Vol. 49 (6). Date of Electronic Publication: 2023 May 05.
Publication Type: Journal Article
Journal Info: Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-2431 (Electronic) Linking ISSN: 1021335X NLM ISO Abbreviation: Oncol Rep Subsets: MEDLINE
Database: MEDLINE Complete
Full text is not displayed to guests.
Description
ISSN:1791-2431
DOI:10.3892/or.2023.8561